Genetic correlations between Alzheimer's disease and gut microbiome genera
- PMID: 37002253
- PMCID: PMC10066300
- DOI: 10.1038/s41598-023-31730-5
Genetic correlations between Alzheimer's disease and gut microbiome genera
Abstract
A growing body of evidence suggests that dysbiosis of the human gut microbiota is associated with neurodegenerative diseases like Alzheimer's disease (AD) via neuroinflammatory processes across the microbiota-gut-brain axis. The gut microbiota affects brain health through the secretion of toxins and short-chain fatty acids, which modulates gut permeability and numerous immune functions. Observational studies indicate that AD patients have reduced microbiome diversity, which could contribute to the pathogenesis of the disease. Uncovering the genetic basis of microbial abundance and its effect on AD could suggest lifestyle changes that may reduce an individual's risk for the disease. Using the largest genome-wide association study of gut microbiota genera from the MiBioGen consortium, we used polygenic risk score (PRS) analyses with the "best-fit" model implemented in PRSice-2 and determined the genetic correlation between 119 genera and AD in a discovery sample (ADc12 case/control: 1278/1293). To confirm the results from the discovery sample, we next repeated the PRS analysis in a replication sample (GenADA case/control: 799/778) and then performed a meta-analysis with the PRS results from both samples. Finally, we conducted a linear regression analysis to assess the correlation between the PRSs for the significant genera and the APOE genotypes. In the discovery sample, 20 gut microbiota genera were initially identified as genetically associated with AD case/control status. Of these 20, three genera (Eubacterium fissicatena as a protective factor, Collinsella, and Veillonella as a risk factor) were independently significant in the replication sample. Meta-analysis with discovery and replication samples confirmed that ten genera had a significant correlation with AD, four of which were significantly associated with the APOE rs429358 risk allele in a direction consistent with their protective/risk designation in AD association. Notably, the proinflammatory genus Collinsella, identified as a risk factor for AD, was positively correlated with the APOE rs429358 risk allele in both samples. Overall, the host genetic factors influencing the abundance of ten genera are significantly associated with AD, suggesting that these genera may serve as biomarkers and targets for AD treatment and intervention. Our results highlight that proinflammatory gut microbiota might promote AD development through interaction with APOE. Larger datasets and functional studies are required to understand their causal relationships.
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.FASEB J. 2019 Jul;33(7):8221-8231. doi: 10.1096/fj.201900071R. Epub 2019 Apr 8. FASEB J. 2019. PMID: 30958695 Free PMC article. Clinical Trial.
-
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.J Transl Med. 2023 Aug 10;21(1):535. doi: 10.1186/s12967-023-04335-9. J Transl Med. 2023. PMID: 37563724 Free PMC article.
-
Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.J Mol Neurosci. 2021 Jul;71(7):1436-1455. doi: 10.1007/s12031-021-01829-3. Epub 2021 Apr 8. J Mol Neurosci. 2021. PMID: 33829390 Review.
-
The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.Arch Clin Neuropsychol. 2022 Feb 22;37(3):595-607. doi: 10.1093/arclin/acac008. Arch Clin Neuropsychol. 2022. PMID: 35202456 Free PMC article. Review.
-
Associations between gut microbiota and Alzheimer's disease, major depressive disorder, and schizophrenia.J Neuroinflammation. 2020 Oct 2;17(1):288. doi: 10.1186/s12974-020-01961-8. J Neuroinflammation. 2020. PMID: 33008395 Free PMC article.
Cited by
-
The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review.Life (Basel). 2024 Sep 26;14(10):1234. doi: 10.3390/life14101234. Life (Basel). 2024. PMID: 39459534 Free PMC article. Review.
-
Physical Exercise and Mechanism Related to Alzheimer's Disease: Is Gut-Brain Axis Involved?Brain Sci. 2024 Sep 27;14(10):974. doi: 10.3390/brainsci14100974. Brain Sci. 2024. PMID: 39451988 Free PMC article. Review.
-
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024. Front Pharmacol. 2024. PMID: 39444598 Free PMC article. Review.
-
Investigating Causal Associations between the Gut Microbiota and Dementia: A Mendelian Randomization Study.Nutrients. 2024 Sep 30;16(19):3312. doi: 10.3390/nu16193312. Nutrients. 2024. PMID: 39408279 Free PMC article.
-
Gut Microbiome in Alzheimer's Disease: from Mice to Humans.Curr Neuropharmacol. 2024;22(14):2314-2329. doi: 10.2174/1570159X22666240308090741. Curr Neuropharmacol. 2024. PMID: 39403057 Free PMC article. Review.
References
-
- 2022 Alzheimer’s disease facts and figures. Alzheimer's & Dementia. 18(4), 700–789. 10.1002/alz.12638 (2022). - PubMed
-
- Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–e125. doi: 10.1016/S2468-2667(21)00249-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
